Suppliers / Saga Lifesciences

Saga Lifesciences

India 163 employees Updated 9 July 2026

Saga Lifesciences is a finished-dose manufacturer based in India. It appears in 45 regulatory filings across 4 regulators, without an active US DMF or CEP on file. Its filings concentrate with ZAMRA (ZM), NAFDAC (NG) and TMDA (TZ). Its GMP standing is certified by CDSCO (India), EMA and NAFDAC (NG), among 4 authorities. Customs aggregates show $22.4M of exports covering 1,116 molecules to 47 destinations in 2025.

0
active US DMFs
0
valid CEPs
9
registered plants
45
filings across 4 regulators
These figures were checked against the regulators' own files on 25 July 2026
EU GMP
1 of 1 confirmed
Sources: EudraGMDP (MIA + third-country GMP certs), read 4 May 2026.

Registered plants

Site FDA FEI
Ahmedabad, United Arab Emirates Not on file
Gandhinagar, India Not on file
ahmedabad 382 481ahmedabad, India Not on file
ahmedabad 382 213, India Not on file
ahmedabad, India Not on file
ta sanandchachrawad i vasnaahmedabad, India Not on file

3 further sites are on record.

Filings and GMP by regulator

Regulator Filings GMP certificates
ZAMRA (ZM) 23 None
NAFDAC (NG) 20 1
TMDA (TZ) 1 1
JFDA (JO) 1 None
CDSCO (India) None 9
EMA None 2

Scale

Year Revenue Exports Destinations
2026 YTD Not reported $3.1M 23
2025 Not reported $22.4M 47
2024 Not reported $19.7M 39
2023 Not reported $19.2M 44

Export figures are customs aggregates. We do not publish the identity of any buyer.

Comparing suppliers?

Choose your molecules and target markets. Saga Lifesciences comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability
EudraGMDP and national regulators
GMP certificates
Customs aggregates
Export values, molecule and destination counts